Pharmacogenetics
PharmacoGenetics (PGx) – a Companion Diagnostic
A Pharmacogenetic test helps you choose the right medication and dose for your patient to deliver the best possible outcome and avoid adverse drug reactions. Without a PGx test, you do not know if your patient has a DNA variant which can result in them getting too much or too little of a drug, despite the dose being a standard dose. Many drugs, that your patients may need one day, have been studied for known DNA sequence variants (statins, anaesthetics, anti-blood clotting meds, anti-hypertensives, opioids, antibiotics, anti-diabetics) and guidelines exist to protect your patient. PGx is highly useful as a companion or pre-emptive test in cardiology and can be used post treatment, to explain why inefficacy or adverse drug reaction were observed.
Pharmacogenetics (PGx) test:
This test is designed to reduce adverse drug side effects and improve drug efficacy.
Test request form:https://www.eurofins-biomnis.com/referentiel/liendoc/renseignements/INTGB/B110-INTGB-Profil_pharmacogenetique.pdf
